Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality

Abstract

Background:

Disseminated intravascular coagulation (DIC) has been recognized as an urgent and critical condition in patients with sepsis. Therefore, unfamiliar and time-consuming tests or a complex scoring system are not suitable for diagnosis. Sepsis-induced coagulopathy (SIC), a newly proposed category delineated by a few global coagulation tests, has been established as an early warning sign for DIC. The purpose of this study was to elucidate the characteristics of SIC, especially in relation to the score of the International Society on Thrombosis and Haemostasis (ISTH) for overt DIC.

Method:

A data set for 332 patients with sepsis who were suspected to have DIC, antithrombin activity <70%, and treated with antithrombin substitution was utilized to examine the relationship between SIC and overt DIC. The performance of SIC calculated at baseline (ie, before treatment) as well as on days 2, 4, or 7 was analyzed in terms of its ability to predict 28-day mortality and overt DIC.

Results:

At baseline, 149 (98.7%) of 151 patients with overt DIC according to the ISTH definition were diagnosed as having SIC. Of the 49, 46 (93.9%) patients who developed overt DIC between days 2 and 4 had received a prior diagnosis of SIC. The sensitivity of baseline SIC for the prediction of death was significantly higher than that of overt DIC (86.8% vs 64.5%, P < .001). The sensitivity of SIC on days 2, 4, and 7 was significantly higher than those of overt DIC (96.1%, 92.3%, and 84.4% vs 67.1%, 57.7%, and 50.0%, P < .001, .001, and .001, respectively), although the specificity of SIC was lower at all time points.

Keywords

disseminated intravascular coagulation sepsis diagnostic criteria platelet count prothrombin time

Get full access to this article

View all access options for this article.

References

Taylor

Toh

Hoots

Wada

Levi

. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327–1330.

Ranieri

Thompson

Barie

, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366(22):2055–2064.

Rhodes

Evans

Alhazzani

, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552.

Hayakawa

Yamakawa

Saito

, et al. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study. Thromb Haemost. 2016;115(6):1157–1166.

Tagami

Matsui

Horiguchi

Fushimi

Yasunaga

. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost. 2014;12(9):1470–1479.

Iba

Thachil

. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan. Int J Hematol. 2016;103(3):253–261.

Iba

Gando

Thachil

. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan. J Thromb Haemost. 2014;12(7):1010–1019.

Nishida

Ogura

Egi

, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). Acute Med Surg. 2018;5(1):3–89.

Umemura

Yamakawa

Ogura

Yuhara

Fujimi

. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2015;14(3):518–530.

10.

Yamakawa

Umemura

Hayakawa

, et al. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan. Crit Care. 2016;20(1):229.

11.

Gando

Iba

Eguchi

, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34(3):625–631.

12.

Singer

Deutschman

Seymour

, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810.

13.

Iba

Di Nisio

Thachil

, et al. Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity. Crit Care. 2016;20:287.

14.

Asakura

Takahashi

Uchiyama

, et al. Proposal for new diagnostic criteria for DIC from the Japanese society on thrombosis and hemostasis. Thromb J. 2016;14:42.

15.

Gando

Levi

Toh

. Disseminated intravascular coagulation. Nat Rev Dis Prim. 2016;2:16037.

16.

Hack

. Fibrinolysis in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27(6):633–638.

17.

Iba

Di Nisio

Thachil

, et al. A proposal of the modification of Japanese Society on Thrombosis and Hemostasis (JSTH) disseminated intravascular coagulation (DIC) diagnostic criteria for sepsis-associated DIC. Clin Appl Thromb Hemost. 2018;24(3):439–445. doi:10.1177/1076029617720069.

18.

Iba

Di Nisio

Levy

Kitamura

Thachil

. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7(9):e017046.

19.

Levi

Schultz

. What do sepsis-induced coagulation test result abnormalities mean to intensivists? Intensive Care Med. 2017;43(4):581–583.

20.

Semeraro

Ammollo

Semeraro

Colucci

. Coagulopathy of acute sepsis. Semin Thromb Hemost. 2015;41(6):650–658.

21.

Gando

Saitoh

Ogura

, et al. A multicenter, prospective validation study of the Japanese association for acute medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care. 2013;17(3):R111.

22.

Ogura

Gando

Saitoh

, et al. Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. J Infect Chemother. 2014;20(3):157–162.

23.

Toh

Hoots

. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 2007;5(3):604–606.

24.

Iba

. The meanings of DIC diagnostic criteria. Thromb Res. 2012;129(5):e269–e270.

25.

Takemitsu

Wada

Hatada

, et al. Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost. 2011;105(1):40–44.

26.

Meziani

Gando

Vincent

. Should all patients with sepsis receive anticoagulation? Yes. Intensive Care Med. 2017;43(3):452–454.

27.

van der Poll

Opal

. Should all septic patients be given systemic anticoagulation? No. Intensive Care Med. 2017;43(3):455–457.

28.

Tagami

Matsui

Fushimi

Yasunaga

. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis. Thromb Haemost. 2015;114(3):537–545.

29.

Wada

Thachil

Di Nisio

, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013;11:761–767.